Abstract:Two-dimensional (2D) Pd-based nanomaterials with strong near-infrared absorption have recently shown great application prospects in cancer diagnosis and therapy. Most previous studies mainly focused on understanding the in vivo behaviors and treatment effects of these Pd-based nanomaterials after intravenous injection into mice. However, it remains unclear whether other administration routes will affect the in vivo biodistribution, excretion and potential toxicity of Pd-based nanomaterials. In this study, for the first time we systematically explored the in vivo behaviors of different-sized Pd nanosheets (NSs) (approximately 5 nm, 30 nm and 80 nm) following oral feeding and intraperitoneal injection. It was found that Pd NSs with oral administration had a rather low accumulation that decreased with time in all examined organs, and became almost undetectable in these organs at 24 h post-injection. In comparison, the intraperitoneally injected Pd NSs exhibited obvious time-dependent and size-dependent accumulations in the reticuloendothelial (RES) system including the liver and spleen within 24 h post-injection, and then the accumulation amounts decreased with the lapse of time. Moreover in tumor tissue, smaller-sized Pd NSs (5 nm) had a higher uptake than larger-sized Pd NSs (30 nm and 80 nm). Excretion studies uncovered that more than 70% ID of Pd NSs could be rapidly excreted from the body through urine and feces within two days after oral administration, whereas Pd NSs with intraperitoneal injection could be gradually cleared, mainly via urine within 8 days. Further histological examination of organ sections and blood biochemical analysis evidenced that these different-sized Pd NSs do not cause obvious toxicity in the treated mice at the tested period with the given dose. These results not only indicate that the biodistribution and excretion capabilities of Pd NSs are closely related to their administration routes, but also imply that the intraperitoneally injected Pd NSs have greater potential for in vivo biomedical studies compared to oral feeding, because of their relatively higher tissue absorption and gradual excretion from the body. This study will provide valuable information for the clinical translation of 2D Pd-based nanomaterials.

Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and Metabolomics

Toxicological Evaluation of Prussian Blue Nanoparticles after Short Exposure of Mice.

Biosafety and Biocompatibility Assessment of Prussian Blue Nanoparticles in Vitro and in Vivo.

Systemic effects of nanoplastics on multi-organ at the environmentally relevant dose: The insights in physiological, histological, and oxidative damages

Evidence on Invasion of Blood, Adipose Tissues, Nervous System and Reproductive System of Mice After a Single Oral Exposure: Nanoplastics versus Microplastics

Subacute Exposure to Black Phosphorus Quantum Dots Induces Cardiac Fibrosis and the Potential Role of Gut Microbiota

Silver Nanoparticles Induced Oxidative and Endoplasmic Reticulum Stresses in Mouse Tissues: Implications for the Development of Acute Toxicity after Intravenous Administration.

Susceptibility of Overweight Mice to Liver Injury As a Result of the ZnO Nanoparticle-Enhanced Liver Deposition of Pb2.

Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys

Acute Toxic Effects and Gender‐related Biokinetics of Silver Nanoparticles Following an Intravenous Injection in Mice

Blood uptake and urine excretion of nano- and micro-plastics after a single exposure

The biodistribution, excretion and potential toxicity of different-sized Pd nanosheets in mice following oral and intraperitoneal administration.

Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery

Biodistribution and toxicity of intravenously administered silica nanoparticles in mice

Bioaccumulation And Toxicity Of Carbon Nanoparticles Suspension Injection In Intravenously Exposed Mice

Nickel Nanoparticles Induced Hepatotoxicity in Mice via Lipid-Metabolism-Dysfunction-Regulated Inflammatory Injury.

A physiologically based toxicokinetic model for microplastics and nanoplastics in mice after oral exposure and its implications for human dietary exposure assessment

Results of a 30-day safety assessment in young mice orally exposed to polystyrene nanoparticles

Toxicity to the Male Reproductive System after Exposure to Polystyrene Nanoplastics: A Macrogenomic and Metabolomic Analysis

Gut Microbiota Dysbiosis Mediates Mouse Kidney Fibrosis Induced by Black Phosphorus Quantum Dots

Understanding the Metabolic Fate and Assessing the Biosafety of MnO Nanoparticles by Metabonomic Analysis